IDO Inhibitor Study for Relapsed or Refractory Solid Tumors

Clinical trial NCT00739609 · TERMINATED

Trial details

NCT number: NCT00739609
Sponsor: NewLink Genetics Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Melanoma Pancreatic Cancer Solid Tumors

Start date: 2008-08-01
Primary completion: 2012-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.